Search

Your search keyword '"Kallieri Maria"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Kallieri Maria" Remove constraint Author: "Kallieri Maria" Database Unpaywall Remove constraint Database: Unpaywall
31 results on '"Kallieri Maria"'

Search Results

1. Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study

2. Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

3. Autoimmune Pulmonary Alveolar Proteinosis (aPAP) in Greece: 20 years in progress

4. Comparison of patients hospitalized for COVID-19 in the periods of Delta and Omicron variants dominance in Greece

5. The clinical experience of patients with severe asthma and previous treatment with omalizumab, choosing mepolizumab in Greece.

6. Diffuse panniculitis in a teen male with ZZ alpha1-antitrypsin deficiency

7. Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective

8. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

9. Sestrin 2 levels are associated with emphysematous phenotype of COPD

10. COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study

11. RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

12. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

13. Autoimmune PAP (aPAP) in children

14. Pulmonary hemorrhage in patients receiving anti-platelets- a case series and a suggested therapeutic algorithm

15. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

16. COVID-19: the day after

17. Vedolizumab-induced acute interstitial lung injury in a 39-year-old male with ulcerative colitis

18. Device use errors among patients with asthma and COPD and the role of training: a real-life study

19. Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study

20. Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece

21. Devise use errors among patients with asthma and COPD-A real-life study

22. Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET/CT study

23. Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis

24. Mycophenolate mofetil as an alternative treatment in sarcoidosis

25. Lung disease caused by non-null ABCA3 mutations: long-term follow-up

26. TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients

27. The effects of pulmonary rehabilitation in patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)

28. Mycophenalate Mofetil as a corticosteroid- sparing agent in patients with sarcoidosis.

Catalog

Books, media, physical & digital resources